New CAR T cell therapy using double target aimed at solid tumors
Chimeric antigen receptors (CARs), engineered from a patient's own immune cells, have been successful for treating blood cancers, but using CARs for solid tumors has been limited by side effects to normal tissues containing ...
Jun 21, 2016
0
26